CUP syndrome-diagnostics from the perspective of pathology

被引:2
|
作者
Pauli, Chantal [1 ,2 ]
机构
[1] Univ Spital Zurich, Inst Pathol Molekularpathol, Zurich, Switzerland
[2] Univ Spital Zurich, Inst Pathol Molekularpathol, Ramistr 100, CH-8091 Zurich, Switzerland
来源
RADIOLOGIE | 2023年 / 63卷 / 5期
关键词
Cancer of unknown primary; Neoplasm metastasis; Immunohistochemistry; Lineage differentiation; Molecular diagnostics; UNKNOWN PRIMARY SITE; IMMUNOHISTOCHEMICAL APPROACH; DIFFERENTIAL-DIAGNOSIS; IDENTIFICATION; CARCINOMA; CANCERS; VIMENTIN; BIOLOGY;
D O I
10.1007/s00117-023-01143-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Problem: Histologic and immunohistologic workup of tumor material from metastases of a previously unknown primary tumor is important for identifying their origin, but is often insufficient for this purpose without clinical oncologic and radiologic evaluation.Procedure: In the initial cancer of unknown primary (CUP) situation, histologic and immunohistochemical workup together with clinicoradiologic correlations contribute significantly to the identification of the primary tumor. There are now accepted guidelines to follow when there is an initial CUP situation. Molecular diagnostic tools can be used to investigate changes at the nucleic acid level, which can provide clues about the primary tumor, including potential targets for therapy. If, despite broad and interdisciplinary diagnostics, it is not possible to identify the primary tumor, the diagnosis is CUP syndrome. If a true CUP situation is present, it is important to assign the tumor to a tumor class or a specific therapy-sensitive subgroup as best as possible so that the best possible treatment can be given. However, for a final assignment to a primary tumor or a final classification as CUP, a comparison with medical oncological and imaging findings is indispensable.Conclusion: When CUP is suspected, close interdisciplinary collaboration between pathology, medical oncology, and imaging is essential to achieve a viable classification as CUP or identification of a presumptive primary tumor, in the interest of providing the most specific and effective therapy for affected individuals.
引用
收藏
页码:336 / 345
页数:10
相关论文
共 50 条
  • [41] Fact sheet: epidemiology of CUP syndrome in Germany
    Zeissig, Sylke Ruth
    Kraywinkel, Klaus
    ONKOLOGIE, 2024, 30 : 161 - 165
  • [42] Implementation of TMA and digitalization in routine diagnostics of breast pathology
    Rossing, Henrik Holm
    Talman, Maj-Lis Moller
    Laenkholm, Anne-Vibeke
    Wielenga, Vera Timmermans
    APMIS, 2012, 120 (04) : 341 - 347
  • [43] Economic, regulatory, and practice issues in molecular pathology and diagnostics
    Ross, JS
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (01) : S7 - S10
  • [44] Fact sheet: epidemiology of CUP syndrome in Germany
    Zeissig, Sylke Ruth
    Kraywinkel, Klaus
    ONKOLOGIE, 2024, 30 : 161 - 165
  • [45] Retinal pathology of a patient with Goldmann-Favre Syndrome
    Bonilha, Vera L.
    Fishman, Gerald A.
    Rayborn, Mary E.
    Hollyfield, Joe G.
    OPHTHALMIC GENETICS, 2009, 30 (04) : 172 - 180
  • [46] Faktenblatt: Epidemiologie des CUP-Syndroms in DeutschlandFact sheet: epidemiology of CUP syndrome in Germany
    Sylke Ruth Zeissig
    Klaus Kraywinkel
    Die Onkologie, 2024, 30 (3) : 161 - 165
  • [47] Positronen-Emissions-Tomographie beim CUP-SyndromPositron emission tomography in CUP syndrome
    Manuel Röhrich
    Die Radiologie, 2023, 63 (5) : 354 - 357
  • [48] Systemic therapy of prognostically unfavorable CUP syndrome. Adeno- and undifferentiated carcinoma
    Bochtler, Tilmann
    Kraemer, Alwin
    ONKOLOGE, 2017, 23 (12): : 1000 - 1005
  • [49] Avoiding pitfalls in the diagnostics of bone neoplasms from pathologists point of view. Importance of reference pathology
    Werner, M.
    RADIOLOGE, 2016, 56 (06): : 536 - 542
  • [50] Avoiding pitfalls in the diagnostics of bone neoplasms. Importance of reference pathology
    Werner, M.
    PATHOLOGE, 2014, 35 : 242 - 248